Atrial fibrillation and Sinus node dysfunction

Summary:

Sinus node dysfunction is found among people with Atrial fibrillation, especially for people who are female, 60+ old.

The study analyzes which people have Sinus node dysfunction with Atrial fibrillation. It is created by eHealthMe based on reports of 337 people who have Atrial fibrillation from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Atrial fibrillation?

Atrial fibrillation (fibrillation of the muscles of the atria of the heart) is found to be associated with 2,874 drugs and 3,843 conditions by eHealthMe. Check the latest studies of Atrial fibrillation.

What is Sinus node dysfunction?

Sinus node dysfunction (a group of abnormal heart rhythms) is found to be associated with 1,178 drugs and 840 conditions by eHealthMe. Check the latest studies of Sinus node dysfunction.

On Jan, 22, 2026

337 people who have Atrial Fibrillation and Sinus Node Dysfunction are studied.

Would you have Sinus node dysfunction when you have Atrial fibrillation?

Gender of people who have Atrial fibrillation and experienced Sinus node dysfunction *:

Click here to view

Age of people who have Atrial fibrillation and experienced Sinus node dysfunction *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Sinus node dysfunction?

- Check whether Sinus node dysfunction is associated with a drug or a condition

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Bolognesi M, Bolognesi D, "Medicine Ciprofloxacin-induced paroxysmal atrial fibrillation", , 2014 Mar .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Bolognesi M, Bolognesi D, "Ciprofloxacin-induced paroxysmal atrial fibrilation", OA Case Reports, 2012 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
Bolognesi M, Bolognesi D, "Medicine Ciprofloxacin-induced paroxysmal atrial fibrillation", , 2014 Mar .
Kim DJ, Lee SC, Park GS, Kim GJ, Hwang WT, Lee CS, Lee MH, Hahn DH, Koh HC, "Amiodarone Induced Multiorgan Toxicity in a Patient of Hypertrophic Cardiomyopathy With Atrial Fibrillation", Journal of the Korean Geriatrics Society, 2013 Dec .
Bolognesi M, Bolognesi D, "Ciprofloxacin-induced paroxysmal atrial fibrilation", OA Case Reports, 2012 Jan .

Related studies:

Treatments, associated drugs and conditions:

Atrial fibrillation (349,185 reports)
Sinus node dysfunction (4,617 reports)

Common drugs associated with Sinus node dysfunction:

Aspirin: 545 reports
Digoxin: 318 reports
Furosemide: 308 reports
Lasix: 295 reports
Vioxx: 236 reports
Avandia: 232 reports
Coumadin: 231 reports
Lipitor: 205 reports
Lisinopril: 193 reports
Atenolol: 191 reports
Metformin: 182 reports
Amlodipine: 177 reports
Norvasc: 171 reports
Simvastatin: 165 reports
Fosamax: 160 reports
Plavix: 158 reports
Prednisone: 146 reports
Synthroid: 138 reports
Omeprazole: 135 reports
Diovan: 131 reports
Spironolactone: 130 reports
Zide: 111 reports
Prilosec: 108 reports
Hydrochlorothiazide: 107 reports
Zocor: 106 reports
Carvedilol: 105 reports
Metoprolol tartrate: 104 reports
Nexium: 102 reports

All the drugs that are associated with Sinus node dysfunction:

Sinus node dysfunction (1,178 drugs)

Common conditions associated with Sinus node dysfunction:

Hypertension: 487 reports
High blood pressure: 483 reports
A-fib: 337 reports
Diabetes mellitus aggravated: 222 reports
Diabetes: 221 reports
Multiple myeloma: 169 reports
Osteoporosis: 163 reports
Thin bones: 153 reports
Rheumatoid arthritis aggravated: 124 reports

All the conditions that are associated with Sinus node dysfunction:

Sinus node dysfunction (840 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Sinus node dysfunction and Atrial fibrillation, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.